William Mack & Associates
ELV icon

William Mack & Associates’s Elevance Health ELV Stock Holding History

William Mack & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10.5K Buy
+27
New +$10.8K ﹤0.01% 397

Other funds holding ELV

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $103B AUM 36.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $54.9B AUM 27.38% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

William Mack & Associates's ELV Position: Q3 2026 in Review

William Mack & Associates opened a new position in Elevance Health (ELV) in Q3 2026: 27 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #397 among its holdings.

1,385 funds tracked by Wall St. Rank hold ELV as of Q3 2026.

  • William Mack & Associates held 27 shares of Elevance Health worth $10.5K as of Q3 2026.
  • Elevance Health was a new William Mack & Associates position in Q3 2026.
  • Elevance Health made up ﹤0.01% of William Mack & Associates's portfolio in Q3 2026, its #397 holding.
  • 1,385 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.

Based on William Mack & Associates's 13F filing for Q3 2026, filed 27 Oct 2026.